These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15828173)

  • 21. Antimicrobial susceptibility of Serratia marcescens isolated from clinical materials.
    Igari J; Oguri T; Kosakai N
    Jpn J Antibiot; 1984 Sep; 37(9):1625-30. PubMed ID: 6392599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A beta-lactamase from Serratia marcescens hydrolyzing the 2-carboxypenam T-5575.
    Matsumura N; Mitsuhashi S
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2132-4. PubMed ID: 8540730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
    Ullmann U; Lindemann B
    Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between pigment producibility and drug resistance in Serratia marcescens.
    Muto Y; Tsuji A; Kaneko Y; Goto S
    Microbiol Immunol; 1981; 25(11):1101-8. PubMed ID: 7035842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergism of aminoglycosides and carbenicillin against resistant strains of Serratia marcescens.
    Lin MY; Tuazon CU; Sheagren JN
    J Antimicrob Chemother; 1979 Jan; 5(1):37-44. PubMed ID: 368005
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.
    Bush K; Flamm RK; Ohringer S; Singer SB; Summerill R; Bonner DP
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2203-8. PubMed ID: 1803992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sensitivity of Serratia marcescens to chemotherapy].
    Neguţ M; Niţulescu A; Potcoavă R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1978; 23(1):27-36. PubMed ID: 349661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro synergistic effects of fisetin and norfloxacin against aquatic isolates of Serratia marcescens.
    Dong J; Ruan J; Xu N; Yang Y; Ai X
    FEMS Microbiol Lett; 2016 Jan; 363(1):fnv220. PubMed ID: 26567906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefepime shows good efficacy and no antibiotic resistance in pneumonia caused by Serratia marcescens and Proteus mirabilis - an observational study.
    Yayan J; Ghebremedhin B; Rasche K
    BMC Pharmacol Toxicol; 2016 Mar; 17():10. PubMed ID: 27004519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial susceptibility and multiplex PCR screening of AmpC genes from isolates of Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens.
    Kao CC; Liu MF; Lin CF; Huang YC; Liu PY; Chang CW; Shi ZY
    J Microbiol Immunol Infect; 2010 Jun; 43(3):180-7. PubMed ID: 21291844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific distribution of R factors in Serratia marcescens strains isolated from hospital infections.
    Schaefler S; Winter J; Catelli A; Greene J; Toharski B
    Appl Microbiol; 1971 Sep; 22(3):339-43. PubMed ID: 4940874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidrug resistance in Serratia marcescens and cloning of genes responsible for the resistance.
    Chen J; Lee EW; Kuroda T; Mizushima T; Tsuchiya T
    Biol Pharm Bull; 2003 Mar; 26(3):391-3. PubMed ID: 12612456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic susceptibility of Serratia marcescens and Serratia liquefaciens.
    Traub WH
    Chemotherapy; 2000; 46(5):315-21. PubMed ID: 10965096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection of hyperproduction of AmpC and SME-1 in a carbapenem-resistant Serratia marcescens isolate during antibiotic therapy.
    Hemarajata P; Amick T; Yang S; Gregson A; Holzmeyer C; Bush K; Humphries RM
    J Antimicrob Chemother; 2018 May; 73(5):1256-1262. PubMed ID: 29471486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative studies on antibiotic susceptibility in Serratia marcescens].
    Gulino R; Modde H
    Schweiz Rundsch Med Prax; 1973 Apr; 62(14):428-31. PubMed ID: 4572075
    [No Abstract]   [Full Text] [Related]  

  • 37. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.
    Traub WH
    Chemotherapy; 1983; 29(1):48-57. PubMed ID: 6339180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genes of resistance to aminoglycoside antibiotics in clinical strains of Serratia marcescens and the enzyme encoded by them].
    Kolganov AN; Vakulenko SB
    Antibiot Khimioter; 1992 Nov; 37(11):10-4. PubMed ID: 1300924
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Killing of Serratia marcescens biofilms with chloramphenicol.
    Ray C; Shenoy AT; Orihuela CJ; González-Juarbe N
    Ann Clin Microbiol Antimicrob; 2017 Mar; 16(1):19. PubMed ID: 28356113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Umbelliprenin from Ferula persica roots inhibits the red pigment production in Serratia marcescens.
    Iranshahi M; Shahverdi AR; Mirjani R; Amin G; Shafiee A
    Z Naturforsch C J Biosci; 2004; 59(7-8):506-8. PubMed ID: 15813369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.